Document Detail

Heparin-induced Extracorporal LDL precipitation (H.E.L.P) in diabetic foot syndrome - preventive and regenerative potential?
MedLine Citation:
PMID:  18622889     Owner:  NLM     Status:  MEDLINE    
Peripheral arterial disease is more aggressive in concomitant diabetes posing an increased risk for critical limb ischemia and subsequent limb loss. The majority of therapies available are not effective to prevent amputation in patients with severe disease. The current observational study reports the effect of the heparin-induced extracorporal LDL-precipitation (H.E.L.P.) as a novel therapeutic approach in patients with severe diabetic foot syndrome. Seventeen diabetic patients with septic foot lesions recruited from the diabetic outpatient clinic underwent H.E.L.P. apheresis regularly until fibrinogen levels were stabilized at 3 g/l or infection was controllable as evidenced by alleviation of necrosis. Patients were subsequently followed up for 2 to 73 months. Fibrinogen levels were reduced by 68% after H.E.L.P. treatment. No severe complications were noted. Necrosis could be confined in sixteen patients. Minor amputations were indicated in twelve patients. Three patients underwent major amputations of the lower limb and two patients received surgical reconstruction. In conclusion, H.E.L.P. apheresis may offer an alternative therapeutic option to diabetic patients with critically ischemic feet and appears to have a beneficial major/minor amputation ratio.
H Rietzsch; I Panzner; T Selisko; U Julius; N Jabs; M Reimann; E Bonifacio; M Bornhäuser; S R Bornstein
Related Documents :
12579 - A metabolic approach to the evaluation of peripheral vascular disease.
22147839 - Catheter ablation of right atrial ganglionated plexi in patients with vagal paroxysmal ...
2974849 - Outcome in patients with failed percutaneous transluminal angioplasty for peripheral va...
7371649 - Phantom and amputation illusions in paraplegic patients.
19223609 - Long-term prognosis of diabetic patients with critical limb ischemia: a population-base...
2342009 - Management of congenital arteriovenous malformations.
24527209 - Evaluation of a multiplex elisa for autoantibody profiling in patients with autoimmune ...
932379 - Sleep deprivation in the treatment of elderly depressed patients.
6476229 - Negative findings at appendectomy.
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme     Volume:  40     ISSN:  0018-5043     ISO Abbreviation:  Horm. Metab. Res.     Publication Date:  2008 Jul 
Date Detail:
Created Date:  2008-07-14     Completed Date:  2008-10-06     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0177722     Medline TA:  Horm Metab Res     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  487-90     Citation Subset:  IM    
Technical University of Dresden, Department of Medicine III.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amputation / rehabilitation
Blood Component Removal / methods*
Blood Viscosity / physiology
Chemical Precipitation
Diabetic Foot / physiopathology,  therapy*
Extracorporeal Circulation* / methods
Heparin / pharmacology*
Limb Salvage / methods*
Lipoproteins, LDL / drug effects,  metabolism*
Middle Aged
Wound Healing / physiology*
Reg. No./Substance:
0/Lipoproteins, LDL; 9005-49-6/Heparin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Microstructural analysis of ingestive behaviour reveals no contribution of palatability to the incom...
Next Document:  The European perspective of diabetes prevention.